TFF3 and cancer: However, since a previous modeling study suggested that the Cytosponge-TFF3 test combined with endotherapy for treating early cancer had cost advantages over endoscopy [34], this approach may open up the possibility for more systematic diagnosis of a broader subgroup of the population in the future.